Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on CD19+ Lymphoid Disease Using Genetically Modified T Cells for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma

    Recruiting

    1 1
    Germany
  • Study of adalimumab and infliximab dose adjustment guided by fecal calprotectin monitoring in adolescents and young adults with Crohn’s disease or ulcerative colitis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands Spain
  • Study on Cerebrolysin and Sodium Chloride for Patients with CADASIL

    Recruiting

    1 1
    Investigated diseases:
    Czechia
  • Study of VX-121, Tezacaftor, and Deutivacaftor for Children Aged 1-11 with Cystic Fibrosis

    Recruiting

    1 1 1 1
    Investigated diseases:
    France Germany The Netherlands Sweden
  • Study on Stopping or Continuing Anastrozole, Letrozole, and Exemestane for Patients with Advanced or Metastatic Low-Grade Endometrial Stromal Sarcoma

    Recruiting

    1 1 1
    France
  • Title: Study of gentamicin, vancomycin and cefazolin antibiotics to prevent infections in women having breast reconstruction surgery with implants

    Recruiting

    1 1 1
    Investigated diseases:
    Denmark
  • Study on the Safety of Ticagrelor and Aspirin in Patients with ST-Elevation Myocardial Infarction After Heart Procedure

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on PET/CT Imaging with [18F]-AlF-FAPI-74 for Identifying Fibrosis and Inflammation in Patients with Progressive Pulmonary Fibrosis

    Recruiting

    1 1
    Investigated drugs:
    The Netherlands
  • Study on Levothyroxine and Low-Calorie Diet for Weight Loss in Obese Patients with Subclinical Hypothyroidism or High-Normal TSH Levels

    Recruiting

    1 1 1
    Investigated diseases:
    Spain
  • Study of Regorafenib with BRAF/MEK-Inhibitor Combination for Patients with Advanced Melanoma After Previous Treatment

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium